News for hackers. Stuff that matters.
Re:Has esketamine been overhyped? by DanBC on Wednesday July 31, 2019 @04:14AM (#20572533)
The drug is licensed for people with treatment resistant depression. This group has significantly higher risk of death by suicide. I dislike speculating on causes of suicides, but if they've been told "here's this thing that appears to give relief from depression for people like you", and they try it, and it doesn't, I can see how that would further increase their risk.

There are no comments on this comment yet.